Olmesafe 40 Tablet

About Olmesafe 40 Tablet

Olmesafe 40 is a tablet from Orion Pharma Ltd., with the generic name Olmesartan Medoxomil. Olmesafe 40 is used for the treatment of hypertension (high blood pressure) in adults.

There are 29 brands of Olmesartan Medoxomil listed in Bangladesh. The lowest listed price is Belsar 10 mg Tablet at ৳ 6.00 per unit.

What is Olmesafe 40 Tablet?

Olmesafe 40 40 mg is a tablet product of Orion Pharma Ltd. that contains Olmesartan Medoxomil. By blocking this effect, the medicine helps blood vessels relax. The medicine works by blocking the action of angiotensin-II, a substance in the body that narrows blood vessels, thereby helping to lower blood pressure. The doctor decides the appropriate dose and course for each patient.

Uses of Olmesafe 40

Olmesafe 40 is used for the treatment of hypertension (high blood pressure) in adults. Lowering blood pressure helps reduce the risk of health problems associated with high blood pressure. It can be taken alone or together with other medicines that lower blood pressure. Your doctor will decide if it is suitable for you.

How to use Olmesafe 40

Take it exactly as the doctor advises. Olmesafe 40 is taken by mouth. Swallow the tablet with water. Swallow the tablet as your doctor or pharmacist advises. Do not change the dose or stop early without asking your doctor. If you miss a dose or are unsure about anything, ask your doctor or pharmacist rather than guessing.

Side effects of Olmesafe 40

Changes in some blood test results have also been reported. Less common effects include chest pain, swelling of the limbs and arthritis. If any side effect troubles you or does not settle, tell your doctor or pharmacist. Tell your doctor if you notice any side effect that bothers you or does not go away. Contact your doctor if you notice anything unusual after taking it.

Safety and precautions

If you are breastfeeding, discuss with your doctor because it is not known if the medicine passes into breast milk. Patients with kidney problems or severe heart failure should inform their doctor before starting this medicine. This medicine is not recommended during pregnancy, especially in the second and third trimesters, as it can harm the unborn baby. The doctor will decide if Olmesafe 40 is safe for you.

Frequently asked questions

Why is Olmesafe 40 prescribed?

Olmesafe 40 is used for the treatment of hypertension (high blood pressure) in adults. Lowering blood pressure helps reduce the risk of health problems associated with high blood pressure.

How is Olmesafe 40 used?

Take it exactly as the doctor advises. Olmesafe 40 is taken by mouth.

What are the side effects of Olmesafe 40?

Changes in some blood test results have also been reported. Less common effects include chest pain, swelling of the limbs and arthritis.

Who should be careful with Olmesafe 40?

If you are breastfeeding, discuss with your doctor because it is not known if the medicine passes into breast milk. Patients with kidney problems or severe heart failure should inform their doctor before starting this medicine.

Indications

Olmesartan Medoxomil is indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents.

Pharmacology

Angiotensin-II formed from angiotensin-I in a reaction catalyzed by angiotensin-converting enzyme (ACE), is a potent vasoconstrictor, the primary vasoactive hormone of the renin-angiotensin system and an important component in the pathophysiology of hypertension. It also stimulates aldosterone secretion by the adrenal cortex. Olmesartan blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin-II by selectively blocking the binding of angiotensin-II to the AT 1 receptor found in many tissues (e.g. vascular smooth muscle, adrenal gland). In-vitro-binding studies indicate that Olmesartan is a reversible & competitive inhibitor of AT 1 receptor. Olmesartan does not inhibit ACE (kinase-I, the enzyme that converts angiotensin-I to angiotensin-II and degrades bradykinin).

Dosage & Administration

Dosage must be individualized. The usual recommended starting dose of Olmesartan is 20 mg once daily when used as monotherapy in patients who are not volume-contracted. For patients requiring further reduction in blood pressure after 2 weeks of therapy, the dose of Olmesartan may be increased to 40 mg. Doses above 40 mg do not appear to have a greater effect. Twice-daily dosing offers no advantage over the same total dose given once daily.

No initial dosage adjustment is recommended for elderly patients, for patients with moderate to marked renal impairment (creatinine clearance <40 ml/min) or with moderate to marked hepatic dysfunction. For patients with possible depletion of intravascular volume (e.g. patients treated with diuretics, particularly those with impaired renal function), Olmesartan should be initiated under close medical supervision and consideration should be given to use of a lower starting dose. Olmesartan may be administered with or without food.

Interaction

With medicine: No significant drug interactions were reported in which Olmesartan was co-administered.
With food & others: Food does not affect the bioavailability of Olmesartan.

Contraindications

Olmesartan is contraindicated in patients who are hypersensitive to any component of this product.

Side Effects

Common: The most common side effects include Back pain, bronchitis, creatine phosphokinase increased, diarrhea, headache, hematuria, hyperglycemia, hypertriglyceridemia, influenza-like symptoms, pharyngitis, rhinitis, and sinusitis.

Rare: Chest pain, peripheral edema, arthritis.

Pregnancy & Lactation

Pregnancy: When pregnancy is detected, discontinue this product as soon as possible. When used in pregnancy during the second and third trimesters, drugs that act directly on the renin-angiotensin system can cause injury and even death to the developing fetus.

Nursing Mothers: It is not known whether Olmesartan is excreted in human milk, but Olmesartan is secreted at low concentration in the milk of lactating rats. Because of the potential for adverse effects on the nursing infant, a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

Precautions & Warnings

As a consequence of inhibiting the renin-angiotensin-aldosterone system, changes in renal function may be anticipated in susceptible individuals treated with olmesartan medoxomil. In patients whose renal function may depend upon the activity of the renin-angiotensin-aldosterone system (e.g. patients with severe congestive heart failure), treatment with angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists has been associated with oliguria and/or progressive azotemia and (rarely) with acute renal failure and/or death. Similar results may be anticipated in patients treated with olmesartan medoxomil.

Overdose Effects

Symptoms: There is no experience of overdose with Olmesartan. The most likely effects of olmesartan medoxomil overdosage are hypotension and tachycardia; bradycardia could be encountered if parasympathetic (vagal) stimulation occurred.

Treatment: If intake is recent, gastric lavage or induction of emesis may be considered. Clinically significant hypotension due to an overdose of Olmesartan requires the active support of the cardiovascular system, including close monitoring of heart and lung function, the elevation of the extremities, and attention to circulating fluid volume and urine output.

Storage Conditions

Store in cool & dry place below 30ºC, protect from light & moisture. Keep out of the reach of children.

Alternative brands of Olmesartan Medoxomil

Other brands with the same generic name, cheapest first.

See all 29 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.